4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 236,311 | 78,569 | 52,351 | 108,298 | 113,484 |
| Marketable Securities | 74,032 | 121,885 | 161,203 | 119,417 | 127,604 |
| TOTAL | $317,776 | $207,040 | $220,511 | $232,478 | $246,523 |
| Non-Current Assets | |||||
| PPE Net | 21,295 | 21,614 | 22,262 | 22,052 | 21,097 |
| Investments And Advances | 0 | 1,405 | 4,908 | 11,122 | 20,532 |
| Other Non-Current Assets | 13,432 | 13,962 | 14,165 | 14,512 | 14,784 |
| TOTAL | $34,727 | $36,981 | $41,335 | $47,686 | $56,413 |
| Total Assets | $352,503 | $244,021 | $261,846 | $280,164 | $302,936 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,493 | 2,408 | 3,322 | 1,480 | 3,316 |
| Accrued Expenses | 6,577 | 5,414 | 8,870 | 7,244 | 6,163 |
| TOTAL | $13,749 | $11,278 | $15,731 | $13,564 | $14,331 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 576 | 778 | 884 | 2,207 | 2,256 |
| Other Non-Current Liabilities | 12,763 | 13,253 | 13,702 | 14,155 | 14,636 |
| TOTAL | $13,610 | $14,137 | $14,778 | $15,156 | $16,088 |
| Total Liabilities | $27,359 | $25,415 | $30,509 | $28,720 | $30,419 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,053 | 33,260 | 33,234 | 32,392 | 32,382 |
| Common Shares | 4 | 3 | 3 | 3 | 3 |
| Retained earnings | -372,788 | -343,172 | -314,490 | -287,111 | -261,420 |
| Other shareholders' equity | 345 | -270 | -1,196 | -1,851 | -1,827 |
| TOTAL | $325,144 | $218,606 | $231,337 | $251,444 | $272,517 |
| Total Liabilities And Equity | $352,503 | $244,021 | $261,846 | $280,164 | $302,936 |